Memantine and Stimulant Combination Therapy

Evidence for Safety

• The American Academy of Child and Adolescent Psychiatry's comprehensive practice parameters for stimulant use do not list memantine as a contraindication, with specific warnings including MAO inhibitors, psychosis, glaucoma, and liver disorders 1, 2, 3
• The only absolute contraindication for combining stimulants with other medications is concurrent MAO inhibitor use, which can cause severe hypertension and cerebrovascular accidents 1, 2, 3

Medication Interactions

• Sertraline and stimulants can be safely combined, with guidelines confirming no significant drug-drug interactions between SSRIs and stimulants, though caution is warranted with more potent CYP450 inhibitors 5
• Guanfacine is FDA-approved as adjunctive therapy with stimulants, with this combination specifically recommended in guidelines for ADHD management 7

Monitoring Recommendations

• Cardiovascular parameters, such as blood pressure and heart rate, should be checked at baseline and regularly when combining stimulants and guanfacine 7
• Cognitive effects, including memantine's side effects of headaches and dizziness, may overlap with stimulant side effects and require dose adjustments if symptoms become problematic 4

Common Pitfall to Avoid

• Memantine should not be assumed to treat ADHD symptoms, as it is not indicated for ADHD treatment, with stimulants remaining first-line therapy with 70-80% response rates 6